Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05610969 · ClinicalTrials.gov registry record · Phase 1
Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks
A Phase 1 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT05610969: Clinical Trial Phase 1 study, sponsored by University of Pennsylvania.
NCT05610969 is a Phase 1 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05610969, a Phase 1 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This study is evaluating music vs midazolam as a means of anxiolysis for preoperative single-shot nerve block placement.
Interventions
- DRUG Midazolam
- OTHER Music
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2023-05-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05610969
The ClinicalTrials.gov registry entry for NCT05610969 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Midazolam is the first listed.
NCT05610969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05610969 about?
NCT05610969 is a clinical study titled "Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks". This study is evaluating music vs midazolam as a means of anxiolysis for preoperative single-shot nerve block placement.
What is the current status of trial NCT05610969?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2021-09-01. Estimated completion is 2023-05-08.
What interventions are being tested in trial NCT05610969?
The interventions under investigation include: Midazolam (DRUG), Music (OTHER).
Who is sponsoring clinical trial NCT05610969?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.